TEVA Teva Pharmaceutical Industries Ltd

$31.46 -3.33%

Healthcare · Pharmaceutical Preparations

Teva Pharmaceutical Industries Ltd (TEVA) is a healthcare company in the Pharmaceutical Preparations industry, with a market capitalization of $36.6 billion. Shares last traded at $31.46, 15.7% below their 52-week high. Over the past year the stock is up 86.4%. TEVA trades at a price-to-earnings ratio of 25.98, above the Pharmaceutical Preparations median of 16.82. Net profit margin is 8.2%, above the peer median of -0.1%. Revenue grew 4.3% year over year. The shares yield 15.7% in dividends.

Market Cap

$36.6B

Shares Out

1.16B

EPS (TTM)

$1.72

P/E Ratio

18.29

P/S Ratio

2.12

P/B Ratio

4.45

Dividend / Share

$4.93

Dividend Yield

15.67%

52-Week High

$37.34

52-Week Low

$15.00

Volume

664,327

Avg Vol (3m)

489,792.111

Performance

-8.94%

-7.73%

+6.91%

+4.53%

YTD

+1.70%

+86.40%

Chart

Full chart →

Daily candles · volume · SMA(20)/SMA(50) · Databento EQUS.MINI.

Technicals

RSI (14)

37.03

SMA (50)

$33.62

SMA (200)

$28.76

Price vs SMA50

-6.42%

Price vs SMA200

+9.42%

ATR (14)

$1.16

Financials

Revenue

$17.3B

Net Income

$1.4B

Gross Margin

51.8%

Operating Margin

12.5%

Net Margin

8.2%

Return on Equity

17.1%

Return on Assets

3.5%

Current Ratio

1.01

Debt / Equity

3.50

Revenue Growth (YoY)

+4.3%

Latest reported annual period ending 2025-12-31 · SEC EDGAR/XBRL.

Recent earnings

Period	EPS (diluted)	Reported
Q1 2026	$0.31	2026-04-29
FY 2025	$1.21	2026-02-03
Q3 2025	$0.80	2025-11-05
Q2 2025	$0.43	2025-07-30
Q1 2026	$0.18	2026-04-29
FY 2025	$-1.45	2026-02-03

Full earnings history →

Pharmaceutical Preparations peers

TEVA vs 14 industry peers (Pharmaceutical Preparations), by market cap.

P/E vs peers

25.98 / 16.82 med

+55% premium

P/S vs peers

2.12 / 3.54 med

-40% discount

Net margin vs peers

8.2% / -0.1% med

above median

1–14 of 14


LLY	Lilly (Eli)	$1.04T	50.16	15.88	31.7%	-1.17%
JNJ	Johnson & Johnson	$549.8B	20.51	5.84	28.5%	-2.42%
ONC	Beone Medicines Ltd.	$390.6B	1361.26	73.10	5.4%	+2.83%
ABBV	AbbVie	$382.5B	90.51	6.25	6.9%	-2.16%
MRK	Merck	$281.6B	15.43	4.33	28.1%	-1.30%
ABT	Abbott Laboratories	$154.3B	23.65	3.48	14.7%	+0.09%
PFE	Pfizer	$143.7B	18.50	2.30	12.4%	-2.89%
VRTX	Vertex Pharmaceuticals	$114.6B	28.99	9.55	32.9%	-1.63%
BMY	Bristol Myers Squibb	$110.3B	15.63	2.29	14.6%	-2.35%
REGN	Regeneron Pharmaceuticals	$63.4B	14.08	4.42	31.4%	+0.38%
ALNY	Alnylam Pharmaceuticals	$36.9B	117.57	9.93	8.4%	-1.66%
TEVA	Teva Pharmaceutical Industries Ltd	$36.6B	25.98	2.12	8.2%	-3.33%
ZTS	Zoetis	$33.1B	12.37	3.49	28.2%	+2.09%
RPRX	Royalty Pharma Plc	$23.1B	30.02	9.73	32.4%	-1.30%

Source: SEC EDGAR (fundamentals/EPS/dividends) · Databento EQUS.MINI (prices) · market cap & yield computed by tradmap. Informational only — not financial advice.